| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B Spivak, E Musin, R Mester, N Gonen, Y Talmon, N Guy, S Roitman, M Kupchik, M Kotler, A Weizma. The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents. International clinical psychopharmacology. vol 14. issue 4. 1999-10-14. PMID:10468315. |
the effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents. |
1999-10-14 |
2023-08-12 |
Not clear |
| H Y Meltzer, S R McGur. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia bulletin. vol 25. issue 2. 1999-09-24. PMID:10416729. |
the effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. |
1999-09-24 |
2023-08-12 |
Not clear |
| H Y Meltzer, S R McGur. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia bulletin. vol 25. issue 2. 1999-09-24. PMID:10416729. |
we have identified all the studies of clozapine, olanzapine, and risperidone that provide data on their effects on cognition in schizophrenia. |
1999-09-24 |
2023-08-12 |
Not clear |
| A R Mohn, R R Gainetdinov, M G Caron, B H Kolle. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. vol 98. issue 4. 1999-09-23. PMID:10481908. |
these behavioral alterations are similar to those observed in pharmacologically induced animal models of schizophrenia and can be ameliorated by treatment with haloperidol or clozapine, antipsychotic drugs that antagonize dopaminergic and serotonergic receptors. |
1999-09-23 |
2023-08-12 |
mouse |
| J Judg. Clozapine in schizophrenia. Psychiatric services (Washington, D.C.). vol 50. issue 8. 1999-09-10. PMID:10445662. |
clozapine in schizophrenia. |
1999-09-10 |
2023-08-12 |
Not clear |
| K Stengler-Wenzk. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine]. Psychiatrische Praxis. vol 26. issue 3. 1999-09-08. PMID:10412713. |
[presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine]. |
1999-09-08 |
2023-08-12 |
Not clear |
| K Stengler-Wenzk. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine]. Psychiatrische Praxis. vol 26. issue 3. 1999-09-08. PMID:10412713. |
we report on the case of a 31-year old man with chronic schizophrenia who had shown obsessive-compulsive symptoms during treatment with clozapine. |
1999-09-08 |
2023-08-12 |
Not clear |
| T I Prior, P S Chue, P Tibbo, G B Bake. Drug metabolism and atypical antipsychotics. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 9. issue 4. 1999-09-03. PMID:10422890. |
the introduction of the atypical antipsychotics clozapine, risperidone, olanzapine, quetiapine and sertindole for the treatment of schizophrenia has coincided with an increased awareness of the potential of drug-drug interactions, particularly involving the cytochrome p450 (cyp) enzymes. |
1999-09-03 |
2023-08-12 |
Not clear |
| A Ahokas, E Elone. Circadian rhythm of white blood cells during clozapine treatment. Psychopharmacology. vol 144. issue 3. 1999-09-02. PMID:10435399. |
the atypical antipsychotic clozapine is effective in the treatment of patients with refractory schizophrenia. |
1999-09-02 |
2023-08-12 |
Not clear |
| H Y Lane, W H Chan. Clozapine versus risperidone in treatment-refractory schizophrenia: possible impact of dosing strategies. The Journal of clinical psychiatry. vol 60. issue 7. 1999-08-27. PMID:10453806. |
clozapine versus risperidone in treatment-refractory schizophrenia: possible impact of dosing strategies. |
1999-08-27 |
2023-08-12 |
Not clear |
| R de O Oliveira-Souza, R P Marrocos, W M De Figueired. Sustained long-term improvement with clozapine in schizophrenia. Arquivos de neuro-psiquiatria. vol 57. issue 1. 1999-08-26. PMID:10347718. |
sustained long-term improvement with clozapine in schizophrenia. |
1999-08-26 |
2023-08-12 |
human |
| R de O Oliveira-Souza, R P Marrocos, W M De Figueired. Sustained long-term improvement with clozapine in schizophrenia. Arquivos de neuro-psiquiatria. vol 57. issue 1. 1999-08-26. PMID:10347718. |
clozapine should be tried in every patient with schizophrenia in whom positive symptoms, disorganization, or bizarre behavior are a matter of incapacitation despite efforts to keep them under control with other drugs. |
1999-08-26 |
2023-08-12 |
human |
| A Pinto, S La Pia, R Mennella, D Giorgio, L DeSimon. Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia. Psychiatric services (Washington, D.C.). vol 50. issue 7. 1999-08-26. PMID:10402608. |
cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia. |
1999-08-26 |
2023-08-12 |
Not clear |
| C M Kalinya. Schizophrenia treatment: the use of atypical drugs--risperdal, zyperexa, and clozaril. The international journal of psychiatric nursing research. vol 4. issue 2. 1999-08-26. PMID:10451301. |
schizophrenia treatment: the use of atypical drugs--risperdal, zyperexa, and clozaril. |
1999-08-26 |
2023-08-12 |
Not clear |
| C Guitton, J M Kinowski, M Abbar, P Chabrand, F Bressoll. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia. Journal of clinical pharmacology. vol 39. issue 7. 1999-08-18. PMID:10392327. |
clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia. |
1999-08-18 |
2023-08-12 |
Not clear |
| H C Kales, J R Dequardo, R Tando. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 23. issue 3. 1999-08-17. PMID:10378236. |
combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. |
1999-08-17 |
2023-08-12 |
Not clear |
| H C Kales, J R Dequardo, R Tando. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 23. issue 3. 1999-08-17. PMID:10378236. |
to assess the efficacy and safety of combining electroconvulsive therapy (ect) and clozapine in patients with treatment-resistant schizophrenia, the authors reviewed use of this combination in four treatment-resistant schizophrenic inpatients and one inpatient with schizophrenia who was intolerant of clozapine doses needed to control her psychosis. |
1999-08-17 |
2023-08-12 |
Not clear |
| H C Kales, J R Dequardo, R Tando. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 23. issue 3. 1999-08-17. PMID:10378236. |
the long-term impact of ect on the course of schizophrenia in patients incompletely responsive to clozapine is not fully elucidated. |
1999-08-17 |
2023-08-12 |
Not clear |
| G Facciolà, A Avenoso, M G Scordo, A G Madia, A Ventimiglia, E Perucca, E Spin. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Therapeutic drug monitoring. vol 21. issue 3. 1999-08-03. PMID:10365650. |
in a subsequent study, plasma concentrations of clozapine and its metabolites were determined in 6 patients with schizophrenia stabilized on clozapine therapy (200-400 mg/d) before and after treatment with sodium valproate (900-1200 mg/d) for 4 weeks. |
1999-08-03 |
2023-08-12 |
Not clear |
| K Wahlbeck, M Cheine, A Essali, C Adam. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. The American journal of psychiatry. vol 156. issue 7. 1999-07-30. PMID:10401441. |
evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. |
1999-07-30 |
2023-08-12 |
Not clear |